HBx and transforming growth factor beta 1 (TGF-β1) contribute to the malignant transformation of HPCs into hepatic CSCs, and correlate with the stem cell markers EpCAM and CD90 and the poor survival of HCC patients. The gene discussed is EPCAM; the disease is hepatocellular carcinoma.